相关实验视频
Updated: Sep 16, 2025

08:54
Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
Published on: February 17, 2023
1.2K
刺激激活金属产物用于癌症治疗的近期进展
Jinzhe Liang1, Fangmian Wei2, Hui Chao1,3
1MOE Key Laboratory of Bioinorganic and Synthetic Chemistry Guangdong Basic Research Center of Excellence for Functional Molecular Engineering School of Chemistry Sun Yat-Sen University Guangzhou China.
Smart molecules : open access
|July 8, 2025
概括
金属原制药提供了一个有希望的解决方案,以克服基化疗的局限性,如溶解性差和毒性. 可激活刺激的金属原制药增强了向药物输送和瘤学中的疗效.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 材料科学 材料科学 材料科学
背景情况:
- 基于的药物已获得临床批准,但面临着水溶性差,耐药性和毒性等挑战.
- 这些局限性阻碍了临床试验,并降低了癌症治疗中的疗效.
- 金属制药已经成为解决瘤学中这些问题的策略.
研究的目的:
- 在过去二十年中,回顾刺激活性金属产物近期的进展.
- 探索这些新型药物输送系统的设计,激活机制和生物医学应用.
- 讨论金属制品领域当前的挑战和未来的前景.
主要方法:
- 关于可激活刺激的金属产物药物的文献综述.
- 对内源和外源刺激反应系统的分析.
- 讨论分子结构,激活机制和代表性金属制药的应用.
主要成果:
- 可激活刺激的金属原制药显示出特定部位的传递和向癌症治疗的潜力.
- 可以利用各种内源和外源刺激来激活这些前体药物.
- 智能金属产物显示出最大限度地提高治疗效果的承诺,同时最大限度地减少不良影响.
结论:
- 可激活刺激的金属原制药在克服白金药的局限性方面取得了重大进展.
- 对分子设计和激活策略的进一步研究对于临床转化至关重要.
- 金属原制药对未来的癌症治疗有相当大的前景.
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Prodrugs
3.0K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
3.0K

